herp
simplex
viru
hsv
doublestrand
dna
viru
herpesvirida
famili
infect
oral
mucosa
eye
nasal
mucosa
oropharynx
nervou
system
may
caus
sever
complic
includ
blind
atyp
pneumonia
asept
mening
enceph
even
death
commonli
transmit
sexual
rout
potenti
caus
mening
enceph
hsv
infect
asymptomat
seriou
system
symptom
often
seen
neonat
immunecompromis
individu
incid
sever
hsv
infect
immunocompromis
patient
shown
upward
trend
recent
year
hsv
infect
commonli
treat
nucleosid
analogu
acyclovir
acv
pencyclovir
certain
highli
bioavail
prodrug
valacyclovir
famciclovir
howev
drug
might
promot
viral
mutat
lead
drugresist
hsv
clinic
hsv
isol
immunocompromis
patient
acvresist
urgent
need
develop
new
drug
hsv
infect
hsv
entri
host
cell
divid
three
stage
first
viral
glycoprotein
b
gb
gc
attach
surfac
glycosaminoglycan
host
cell
next
gd
postbind
heparin
sulfat
receptor
last
step
viral
envelop
fuse
plasma
membran
host
cell
penetr
cell
besid
blockag
viral
entri
anoth
strategi
develop
antihsv
drug
regul
viral
gene
express
hsv
viral
gene
classifi
three
cluster
lytic
cycl
hsv
immediateearli
ie
gene
essenti
viral
lytic
cycl
first
transcrib
respons
earli
e
late
l
viral
gene
express
viral
entri
certain
cellular
factor
earli
growth
respons
activ
viral
penetr
promot
viral
lytic
cycl
regul
express
viral
ie
gene
recruit
onto
viral
promot
acceler
viral
replic
lytic
cycl
thu
modul
express
viral
ie
gene
cellular
factor
might
shed
light
develop
therapeut
strategi
hsv
infect
past
develop
antivir
drug
focus
mainli
western
medicin
howev
notic
recent
chines
medicin
antivir
activ
antivir
drug
approv
obtain
natur
product
importantli
studi
report
compound
deriv
chines
medicin
could
block
replic
hsv
ndocosanol
long
chain
alcohol
antihsv
activ
approv
food
drug
administr
fda
topic
treatment
herp
simplex
labiali
veregen
octob
first
botan
medicin
approv
fda
use
treat
genit
wart
caus
human
papilloma
viru
thu
chines
medicin
might
provid
new
roadmap
develop
antivir
drug
houttuynia
cordata
h
cordata
tradit
natur
chines
herbal
medicin
saururacea
famili
use
year
reliev
lungrel
symptom
cough
pneumonia
bronchiti
mani
studi
reveal
inhibitori
effect
h
cordata
viral
infect
hsv
influenza
viru
human
immunodefici
viru
type
sarscov
besid
antivir
activ
h
cordata
also
antiinflammatori
anticanc
antioxid
activ
major
compon
h
cordata
includ
phenol
compound
flavon
alkaloid
flavonoid
compon
quercetin
isoquercitrin
rutin
hyperin
quercitrin
exhibit
antioxid
antimutagen
free
radic
scaveng
capac
phenol
part
includ
chlorogen
acid
antipyret
antibiot
activ
well
known
h
cordata
water
extract
hcwe
exhibit
antihsv
activ
inhibitori
activ
might
affect
activ
hpi
hereaft
defin
secondwav
activ
hsv
infect
howev
molecular
mechan
involv
antihsv
activ
hcwe
thoroughli
explor
yet
whether
hcwe
execut
inhibitori
activ
target
viru
particl
affect
cellular
compon
still
unclear
howev
understand
mechanismofact
moa
identif
target
critic
requisit
new
drug
develop
studi
focus
elucid
moa
hcwe
addit
suppress
activ
identifi
effect
compon
hcwe
hsv
infect
african
green
monkey
kidney
cell
vero
atcc
human
epitheli
carcinoma
cell
atcc
atcc
maintain
dulbecco
modifi
eagl
medium
dmem
modifi
eagl
medium
mem
medium
respect
supplement
fetal
bovin
serum
gibco
unitsml
penicillin
streptomycin
cell
line
cultur
atcc
atcc
stock
propag
vero
cell
aliquot
store
acvresist
gener
previou
studi
g
dri
h
cordata
boil
l
water
hour
supernat
filter
um
filter
lyophil
dri
powder
powder
dissolv
doubledistil
water
concentr
mgml
vero
cell
seed
onto
cultur
plate
hour
infect
pfuwel
viru
hour
incub
virusinfect
cell
wash
twice
phosphatebuff
salin
pb
overlaid
methylcellulos
contain
differ
concentr
hcwe
indic
day
cell
fix
formaldehyd
stain
crystal
violet
plaqu
count
cell
plate
incub
indic
concentr
hcwe
day
cell
wash
pb
ad
mgml
mtt
reagent
tetrazolium
bromid
sigma
incub
hour
incub
mtt
reagent
remov
dmso
ad
well
absorb
determin
elisa
reader
spectramax
molecular
devic
wavelength
nm
cell
pretreat
assay
vero
cell
pretreat
variou
concentr
hcwe
hour
incub
hcwespretr
cell
wash
pb
infect
pfu
hsv
inhibitori
activ
analyz
plaqu
assay
viru
pretreat
assay
pfu
hsv
pretreat
variou
concentr
hcwe
room
temperatur
hour
incub
vero
cell
infect
hcwespretr
viru
analyz
plaqu
assay
viru
bind
assay
vero
cell
first
cool
hour
expos
pfu
hsv
presenc
hcwe
hour
incub
unbound
viru
hcwe
remov
icecold
pb
vero
cell
analyz
plaqu
assay
western
blot
assay
viru
penetr
assay
vero
cell
cool
hour
infect
pfu
hsv
achiev
viral
bind
unbound
virus
remov
vero
cell
incub
hcwe
minut
allow
viral
penetr
vero
cell
wash
neutral
buffer
mm
nacl
mm
kcl
mm
mm
glycin
ph
minut
inactiv
nonpenetr
virus
analyz
plaqu
assay
vero
cell
infect
moi
hsv
hour
absorpt
hcwe
ad
medium
indic
hourspost
infect
hour
total
vero
cell
collect
frozen
thaw
three
time
viru
titer
determin
plaqu
assay
rna
extract
virusinfect
mockinfect
cell
trizol
reagent
invitrogen
treat
dnase
promega
total
rna
subject
revers
transcript
superscript
ii
firststrand
synthesi
system
invitrogen
accord
manufactur
instruct
express
level
viral
gene
measur
sybr
greenbas
realtim
rtpcr
pcr
primer
pair
sequenc
cite
describ
primer
pair
cell
harvest
ripa
lysi
buffer
mm
trishcl
ph
mm
nacl
mm
edta
triton
sd
sodium
deoxychol
mm
pmsf
proteas
inhibitor
cocktail
protein
concentr
measur
bca
protein
assay
biorad
protein
resolv
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
transfer
onto
pvdf
membran
block
skim
milk
trisbuff
salin
tb
mm
trishcl
ph
mm
nacl
react
primari
antibodi
sigma
santa
cruz
santa
cruz
santa
cruz
act
intern
control
promot
region
amplifi
viral
dna
use
follow
primer
set
primer
set
mutf
mutr
use
perform
pcrbase
mutagenesi
ten
mutant
nucleotid
introduc
bind
site
within
viral
promot
pcr
fragment
clone
basic
vector
promega
transfect
carri
triplic
plate
cell
seed
hour
prior
transfect
luciferas
report
construct
along
control
plasmid
prltk
vector
promega
cotransfect
cell
hour
transfect
infect
hsv
moi
luminesc
signal
measur
hpi
multilabel
counter
perkinelm
accord
manufactur
instruct
activ
renilla
luciferas
use
intern
control
normal
transfect
effici
pure
compound
quercetin
isoquercitrin
quercitrin
hyperin
rutin
acyclovir
acv
purchas
sigmaaldrich
dissolv
dimethyl
sulfoxid
dmso
absolut
ethanol
dilut
steril
deioniz
distil
water
use
previou
studi
indic
hcwe
exhibit
promis
antiviru
activ
vero
cell
studi
shed
light
new
direct
develop
antihsv
drug
howev
moa
well
understood
perform
studi
first
measur
antihsv
activ
hcwe
activ
may
differ
previou
report
due
differ
sourc
h
cordata
differ
extract
procedur
cytotox
hcwe
measur
mtt
assay
vero
cell
treat
serial
dilut
hcwe
hour
shown
tabl
hcwe
show
low
cytotox
vero
cell
greater
mgml
next
antihsv
activ
hcwe
determin
plaqu
reduct
assay
result
indic
hcwe
acyclovirresist
hsvar
mgml
mgml
mgml
respect
tabl
intriguingli
hcwe
hsvar
similar
wildtyp
hsv
viru
fact
impli
antivir
mechan
hcwe
acv
might
differ
select
index
si
score
hcwe
hsvar
respect
inhibitori
effect
acv
hsv
also
analyz
acv
hsvar
respect
tabl
demonstr
selfprepar
hcwe
use
could
inhibit
hsv
infect
previou
report
determin
stage
hcwe
hit
identifi
viral
protein
host
factor
mediat
antiviru
activ
first
explor
whether
hcwe
lead
host
cell
initi
antivir
mechan
interfer
viru
particl
directli
block
viral
bind
penetr
vero
cell
hsv
pretreat
respect
hcwe
plaqu
reduct
assay
perform
determin
stage
hcwe
act
hsv
infect
pretreat
vero
cell
show
obvious
inhibitori
effect
infect
concentr
mgml
fig
time
higher
mgml
howev
case
even
hsvar
pretreat
mgml
hcwe
plaqu
format
larg
inhibit
fig
result
impli
antihsv
effect
hcwe
might
target
viru
particl
directli
inhibit
stage
hsv
infect
examin
hypothesi
hcwespretr
incub
vero
cell
allow
viru
bind
onto
cell
penetr
cell
unbound
virus
wash
pb
cellbound
virus
analyz
western
blot
analysi
hcwe
obvious
decreas
cell
bind
abil
dosedepend
manner
fig
result
impli
hcwe
might
affect
viru
particl
directli
result
inhibit
infect
hcwe
interfer
viru
particl
directli
inhibit
hsv
infect
character
inhibitori
mechan
hcwe
identifi
stage
hcwe
act
effect
hcwe
viral
bind
penetr
investig
separ
vero
cell
first
cool
infect
virus
presenc
variou
concentr
hcwe
hour
unbound
virus
hcwe
wash
pb
cellbound
virus
analyz
plaqu
assay
shown
fig
hcwe
inhibit
hsvar
bind
abil
dosedepend
manner
mgml
hcwe
inhibit
hsvar
plaqu
format
respect
acv
serv
neg
control
acv
guanosin
analogu
block
viral
entri
result
indic
plaqu
format
obvious
inhibit
acvtreat
group
addit
viral
bind
also
examin
whether
hcwe
could
influenc
viral
penetr
host
cell
vero
cell
cool
incub
viru
hour
unbound
virus
wash
pb
cell
incub
hcwe
viral
penetr
minut
incub
neutral
buffer
ad
inactiv
nonpenetr
virus
viruspenetr
cell
analyz
plaqu
assay
percentag
inhibit
hsvar
penetr
concentr
mgml
hcwe
respect
fig
precis
realiz
whether
reduct
plaqu
format
induc
hcwe
attribut
blockag
viral
bind
penetr
least
partli
would
determin
effect
hcwe
viral
entri
directli
transloc
viral
tegument
protein
nucleu
express
viral
immediateearli
protein
use
indic
examin
hsv
entri
hcwe
ad
host
cell
viral
bind
penetr
stage
describ
fig
fig
nuclear
fraction
total
protein
extract
examin
viral
transloc
viral
express
western
blot
assay
respect
shown
fig
fig
viral
transloc
viral
express
inhibit
hcwe
bind
penetr
stage
demonstr
hcwe
could
affect
viru
particl
directli
inhibit
viru
infect
viral
envelop
protein
mediat
inhibitori
activ
identifi
hsv
glycoprotein
gd
play
critic
role
viral
bind
onto
host
cell
celltocel
spread
viral
entri
host
cell
determin
whether
gd
target
hcwe
recombin
gd
protein
express
baculoviru
express
system
incub
vero
cell
hour
allow
recombin
gd
bind
onto
vero
cell
unbound
recombin
protein
wash
pb
bound
recombin
protein
detect
western
blot
assay
shown
fig
fig
hcwe
substanti
inhibit
bind
recombin
gd
onto
vero
cell
concentr
mgml
rule
possibl
decreas
recombin
gd
bind
due
protein
degrad
caus
hcwe
recombin
gd
protein
incub
differ
concentr
hcwe
hour
analyz
western
blot
assay
even
highest
concentr
hcwe
lead
gd
degrad
fig
demonstr
hcwe
target
hsv
gd
interfer
viral
bind
penetr
final
block
viral
entri
explor
whether
antihsv
mechan
hcwe
act
viral
entri
timeofaddit
experi
perform
mgml
hcwe
ad
indic
hour
postinfect
hpi
cell
harvest
hpi
cell
lysat
frozen
thaw
three
time
titrat
plaqu
assay
intriguingli
hsv
total
inhibit
even
host
cell
treat
mgml
hcwe
hpi
case
mgml
hcwe
fig
fig
next
investig
whether
hcwe
suppress
viru
replic
regul
viral
late
gene
stage
result
indic
express
level
viral
late
gene
gb
gc
gd
ge
gh
downregul
presenc
hcwe
fig
address
stage
hcwe
suppress
hsv
replic
viral
entri
first
determin
whether
hcwe
influenc
express
viral
protein
vero
cell
first
infect
follow
treatment
hcwe
hour
viral
protein
express
detect
western
blot
assay
shown
fig
mgml
hcwe
obvious
inhibit
protein
express
hpi
ie
gene
respons
viral
e
l
gene
express
also
essenti
viral
lytic
cycl
thu
next
hypothes
hcwe
could
affect
viral
ie
gene
express
suppress
viral
protein
viral
entri
host
cell
infect
follow
treatment
hcwe
rna
extract
hsvinfect
cell
hpi
analysi
express
ie
e
l
gene
respect
realtim
pcr
fig
fig
express
viral
ie
gene
inhibit
hcwe
dosedepend
manner
fig
besid
express
also
determin
result
indic
hcwe
could
regul
viral
ie
gene
express
slightli
fig
furthermor
express
level
e
gene
l
gene
inhibit
hcwe
fold
respect
fig
data
suggest
hcwe
might
suppress
express
viral
gene
inhibit
viral
ie
gene
express
hsv
infect
two
wave
activ
firstwav
activ
could
enhanc
transcript
via
bind
onto
viral
promot
secondwav
activ
could
prevent
host
cell
apoptosi
report
hcwe
block
secondwav
activ
infect
hypothes
whether
hcwe
could
suppress
firstwav
activ
elimin
bind
onto
hsv
promot
test
hypothesi
host
cell
infect
presenc
differ
concentr
hcwe
cell
lysat
harvest
determin
activ
nuclear
fraction
extract
appli
transloc
analysi
western
blot
assay
shown
fig
hcwe
inhibit
transloc
dosedepend
manner
explor
whether
hcwe
could
inhibit
promot
activ
via
inhibit
activ
promot
construct
pgl
luciferas
report
vector
name
wt
transfect
luciferas
activ
wt
transfect
cell
increas
compar
vector
control
pgl
infect
howev
induct
luciferas
activ
suppress
hcwe
fig
although
well
known
express
regul
exact
bind
site
promot
identifi
yet
henc
first
use
transfac
softwar
predict
potenti
bind
site
within
promot
one
bind
site
predict
within
promot
determin
whether
hcwesmedi
suppress
predict
bind
site
within
wt
mutat
pcrbase
mutagenesi
result
plasmid
name
mut
fig
show
luciferas
activ
significantli
decreas
compar
hsv
infect
obviou
suppress
hcwe
treatment
result
impli
promot
activ
least
partli
regul
best
knowledg
besid
viral
promot
potenti
bind
site
identifi
within
viral
ie
gene
promot
might
partial
reason
viral
ie
gene
regul
hcwe
treatment
demonstr
hcwe
inhibit
hsv
infect
vero
cell
multipl
stage
includ
viral
bind
viral
penetr
viral
gene
express
demonstr
antivir
activ
ubiquit
phenomena
differ
human
cell
line
two
addit
human
epitheli
carcinoma
cell
cell
test
cytotox
antihsv
activ
plaqu
reduct
assay
hcwe
show
cytotox
cell
mgml
mgml
importantli
plaqu
reduct
assay
show
hcwe
inhibit
replic
cell
similar
vero
cell
tabl
major
compon
hcwe
identifi
chlorogen
acid
hyperin
rutin
quercetin
quercitrin
isoquercitrin
quercetin
quercitrin
isoquercitrin
show
antihsv
activ
stage
hsv
replic
affect
elucid
clearli
determin
stage
compound
act
pure
compon
analyz
plaqu
reduct
assay
among
compound
rutin
isoquercitrin
quercetin
demonstr
activ
respect
tabl
studi
antihsv
mechan
activ
compound
viru
pretreat
assay
viru
bind
assay
show
quercetin
rutin
isoquercitrin
target
viru
particl
directli
inhibit
viral
entri
fig
fig
furthermor
also
identifi
compound
contribut
inhibit
activ
western
blot
assay
shown
fig
isoquercitrin
quercetin
inhibit
activ
hsv
infect
summari
discov
new
antihsv
mechan
hcwe
hcwe
target
viru
particl
block
viral
bind
penetr
hsv
infect
addit
hcwe
also
inhibit
promot
express
suppress
hsvinduc
activ
therebi
suppress
express
viral
gene
block
synthesi
viral
protein
fig
studi
besid
data
demonstr
hcwe
even
inhibit
hsvar
replic
shed
light
develop
new
antihsv
drug
overcom
surg
drug
resist
hsv
hcwe
affect
multipl
stage
hsv
infect
viral
entri
viral
gene
express
thu
eventu
suppress
hsv
replic
furthermor
quercetin
possess
antihsv
activ
particularli
inhibit
viral
bind
viral
penetr
host
activ
isoquercitrin
suppress
activ
rutin
anoth
major
compon
h
cordata
shown
antihsv
activ
howev
antihsv
mechan
rutin
still
unclear
need
investig
pretreat
hsv
hcwe
block
viral
plaqu
format
obviou
inhibitori
effect
observ
hcwespretr
host
cell
experi
express
transloc
confirm
hcwe
inhibit
viral
entri
bind
penetr
stage
hsv
gd
protein
bind
four
coreceptor
date
includ
herpesviru
entri
mediat
hvem
heparin
sulfat
necessari
viral
postbind
entri
host
cell
uvinactiv
wildtyp
hsv
virion
uvinactiv
virion
lack
gd
solubl
gd
could
block
hsv
infect
impli
viral
gd
ideal
target
develop
antihsv
drug
hcwe
inhibit
bind
recombin
gd
protein
onto
host
cell
fact
indic
hcwe
may
act
hsv
gd
protein
directli
inhibit
viral
entri
stage
viral
bind
penetr
certainli
could
exclud
possibl
viral
glycoprotein
viral
gb
gc
gh
gl
might
involv
inhibit
viral
entri
viral
entri
hcwe
inhibit
viral
ie
gene
e
gene
l
gene
express
furthermor
hcwe
suppress
hsvinduc
activ
attenu
mediat
transcript
one
hsv
ie
gene
could
bind
sever
cellular
protein
well
viral
promot
result
increas
express
viral
e
l
gene
thu
import
gene
express
viral
e
gene
l
gene
regul
hsv
replic
tegument
protein
hsv
bind
host
cell
factor
hcf
form
complex
complex
bind
cellular
protein
stimul
transcript
addit
transactiv
activ
cellular
cisact
element
also
import
regul
express
one
host
transcript
regul
activ
almost
type
cell
mani
type
stimul
inflamm
bacteri
viral
infect
hsv
infect
two
wave
activ
firstwav
trigger
bind
viral
gd
cellular
receptor
activ
recruit
onto
viral
promot
enhanc
express
secondwav
activ
activ
hour
postinfect
could
prevent
host
cell
apoptosi
compound
inhibit
activ
report
exhibit
antihsv
activ
resveratrol
lornixicam
could
downregul
hsv
infectioninduc
impair
viral
ie
gene
express
prevent
recurr
herpet
stromal
kerat
respect
demonstr
hcwe
could
block
hsv
infect
inhibit
secondwav
activ
result
reveal
hcwe
could
also
inhibit
firstwav
activ
howev
timeofaddit
assay
found
mgml
hcwe
could
inhibit
viral
plaqu
format
contrast
posttreat
pretreat
dose
could
suppress
hsv
replic
evid
suggest
inhibitori
activ
hcwe
hsv
might
mainli
come
hcwe
pretreat
taken
togeth
evid
suggest
hcwe
inhibit
hsv
infect
earli
stage
viral
bind
penetr
also
suppress
viru
replic
via
govern
viral
late
gene
viral
entri
howev
whether
inhibitori
mechan
suppress
viral
dna
synthesi
block
viral
packag
also
involv
suppress
viru
replic
stage
need
investig
know
therapeut
efficaci
herb
extract
quit
inconsist
due
differ
herb
speci
product
place
extract
procedur
would
like
identifi
key
compon
hcwe
contribut
antivir
activ
qualiti
pure
compound
much
easier
control
compar
crude
extract
found
rutin
quercetin
isoquercitrin
exhibit
antihsv
activ
previou
report
indic
three
compound
antihsv
activ
though
molecular
mechan
activ
compound
still
unclear
best
knowledg
first
report
present
antihsv
mechan
quercetin
isoquercitrin
present
studi
western
blot
viru
pretreat
assay
reveal
quercetin
could
block
bind
hsv
host
cell
transloc
assay
indic
quercetin
isoquercitrin
block
hsv
replic
inhibit
activ
viru
infect
howev
antihsv
mechan
rutin
still
unclear
moreov
si
valu
isoquercitrin
hsv
greater
studi
indic
potenti
target
drug
develop
quercetin
isoquercitrin
flavonol
compound
similar
structur
wide
distribut
natur
quercetin
shown
inhibitori
effect
lipopolysaccharideinduc
nitric
oxid
synthas
gene
express
inhibit
activ
human
synovi
cell
primari
cultur
rat
proxim
tubul
cell
rat
aortic
smooth
muscl
cell
isoquercitrin
glucosebound
deriv
quercetin
also
shown
antioxid
antiinflamm
properti
recent
flavonol
compound
report
antivir
activ
virus
influenza
polioviru
adenoviru
respiratori
syncyti
viru
sar
coronaviru
hiv
hsv
infect
induc
oxygen
stress
viral
protein
induc
apoptot
cell
death
increas
cellular
reactiv
oxygen
speci
ro
report
quercetin
isoquercitrin
shown
inhibit
hsvinduc
activ
studi
need
clarifi
correl
antioxid
properti
antihsv
activ
quercetin
isoquercitrin
quercetin
small
molecul
studi
show
could
inhibit
hsv
bind
cell
surfac
hypothes
small
molecular
compound
may
compet
gd
bind
site
cellular
receptor
heparin
sulfat
howev
work
need
test
hypothesi
